{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362544419253070720.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.cmpb.2005.04.005"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S016926070500101X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S016926070500101X?httpAccept=text/plain"}}],"dc:title":[{"@value":"PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382544419253070722","@type":"Researcher","foaf:name":[{"@value":"Lars Lindbom"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419253070721","@type":"Researcher","foaf:name":[{"@value":"Pontus Pihlgren"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419253070720","@type":"Researcher","foaf:name":[{"@value":"Niclas Jonsson"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01692607"}],"prism:publicationName":[{"@value":"Computer Methods and Programs in Biomedicine"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2005-09","prism:volume":"79","prism:number":"3","prism:startingPage":"241","prism:endingPage":"257"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S016926070500101X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S016926070500101X?httpAccept=text/plain"}],"createdAt":"2005-07-18","modifiedAt":"2025-09-30","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050571736365471872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Urine volume to hydration volume ratio is associated with pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma."},{"@value":"Urine volume to hydration volume ratio is associated with pharmacokinetics of high‐dose methotrexate in patients with primary central nervous system lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705145167104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707164520576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707532966528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360305192909601920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population pharmacokinetics and pharmacodynamic target attainment analysis of cefazolin using total and unbound serum concentration in patients with prostatectomy or nephrectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185433617280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185727373312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657196768384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population pharmacodynamic analysis of hemoglobin A1c-lowering effects by adding treatment of DPP-4 inhibitors (sitagliptin) in type 2 diabetes mellitus patients based on electronic medical records"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657213552384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Penetration of piperacillin–tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707118424064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Timing of re-dosing based on population pharmacokinetic-pharmacodynamics target attainment analysis of cefmetazole in subjects undergoing lower gastrointestinal surgery"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865815505145472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants"}]},{"@id":"https://cir.nii.ac.jp/crid/1361134273560364032","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhaler"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519194215552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694371860673664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361697223514119040","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A randomized, placebo-controlled, single ascending-dose study to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tralokinumab in Japanese healthy volunteers"}]},{"@id":"https://cir.nii.ac.jp/crid/1363667548357661696","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363949023327842304","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of changes in HbA1c in patients with and without secondary failure after metformin treatments by a population pharmacodynamic analysis using mixture models"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205178223232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of an Integrated Population Pharmacokinetic Model for Oral Levetiracetam in Populations of Various Ages and Ethnicities"}]},{"@id":"https://cir.nii.ac.jp/crid/1390018428978284288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.cmpb.2005.04.005"},{"@type":"CROSSREF","@value":"10.1016/j.jdiacomp.2016.06.009_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1002/jcph.1027_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1002/prp2.883_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1248/bpb.b23-00650_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1128/aac.00267-24_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1111/bcp.13561_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1111/jcpt.12157_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1208/s12248-019-0353-7_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.xphs.2017.04.029_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1007/s40268-021-00365-0_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.jiac.2022.03.024_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1002/psp4.13112_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.jiac.2015.04.015_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2015.08.002_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-13-rg-045_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2017.12.001_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.ijantimicag.2014.05.010_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2021.100403_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2018.08.002_references_DOI_Tc1NamK8wCM29MvVrYxERjtCpab"}]}